Something unexpected is happening in fertility clinics and gynaecology practices around the world. Women who have struggled to conceive for years – many with PCOS, obesity, or insulin resistance – are becoming pregnant after starting GLP-1 receptor agonists like semaglutide (Ozempic, Wegovy) or tirzepatide (Mounjaro). At the same time, a different group of women on these same drugs – women who thought they could not get pregnant – are experiencing unintended pregnancies. Both situations are the result of the same biological mechanism, and understanding it is essential for any woman of reproductive age who is taking or considering a GLP-1 drug.
Key Takeaways
- GLP-1 drugs can restore ovulation in women with PCOS, obesity, or insulin resistance – improving fertility in women who previously could not conceive
- GLP-1 drugs are contraindicated in pregnancy – animal studies show foetal harm; human safety data is limited
- The unintended pregnancy risk is real: restored ovulation combined with oral contraceptive failure (GLP-1 slows absorption) is a documented clinical pattern
- Drugs should be stopped at least 2 months before attempting conception
- GLP-1 drugs do not directly treat infertility – the fertility improvement comes primarily through weight loss and insulin sensitisation
- Hormonal stress management with ashwagandha KSM-66 is a complementary strategy for women managing fertility and cortisol-related hormonal disruption
The Biology: Why GLP-1 Drugs Affect Fertility
GLP-1 receptor agonists work primarily by improving insulin sensitivity and reducing excess body weight. For women with conditions like PCOS, obesity-related anovulation, or hypothalamic dysfunction linked to metabolic stress, these effects directly address the root cause of their fertility challenges.
Here is the chain of events:
- Excess weight and insulin resistance ? elevated insulin ? elevated androgens ? suppressed or irregular ovulation
- GLP-1 drug started ? insulin sensitivity improves, weight decreases ? androgen levels fall ? ovulation resumes
- Ovulation resumes ? pregnancy becomes possible for the first time in years
This is not a speculative mechanism. It is the same reason that weight loss surgery (bariatric surgery) dramatically improves fertility – GLP-1 drugs produce similar metabolic changes through a non-surgical route.
The Unintended Pregnancy Risk – A Growing Clinical Problem
The fertility improvement that GLP-1 drugs produce has created an important and underappreciated clinical risk: unintended pregnancy in women who believed they were infertile or were relying on oral contraceptives for protection.
Two factors combine to create this risk:
Two Risks That Compound Each Other
Restored ovulation surprises women who assumed they were infertile. Many women with PCOS or obesity-related irregular cycles have been told – or have assumed – that conception is unlikely. GLP-1-driven weight loss can restore regular ovulation within weeks to months, well before women realise their fertility status has changed.
GLP-1 drugs slow gastric emptying – which can reduce oral contraceptive absorption. The pill relies on consistent intestinal absorption. Slower gastric motility means hormones from oral contraceptives may be absorbed at lower and more variable levels, potentially reducing contraceptive effectiveness. Both Novo Nordisk and Eli Lilly have included warnings about this in their prescribing information.
What Happens If You Get Pregnant While on a GLP-1 Drug
GLP-1 receptor agonists have not been studied in human pregnancy – it would be unethical to do so. Animal studies, however, show dose-dependent foetal harm, including structural abnormalities. On this basis, all GLP-1 drugs are classified as contraindicated in pregnancy.
If pregnancy is discovered while taking a GLP-1 drug:
- Stop the medication immediately
- Contact your obstetrician and the drug manufacturer’s pregnancy registry (Novo Nordisk for semaglutide, Eli Lilly for tirzepatide)
- The actual risk to human foetuses at clinical doses is not known – but the precautionary position is clear: discontinue immediately
Planning for Pregnancy While on a GLP-1 Drug
For women who want to use GLP-1 drugs for metabolic health and then pursue pregnancy, the recommended approach:
- Achieve your target weight loss goal first, before discontinuing the drug – weight regain is common after stopping, which may reverse the hormonal benefits
- Stop semaglutide at least two months before attempting conception (half-life clears in approximately five weeks; two months provides a safety margin)
- Tirzepatide (Mounjaro) has a similar half-life and the same recommendation
- Maintain the weight loss through diet and exercise during the discontinuation period and through pregnancy
- Use effective contraception (IUD or barrier methods preferred – not oral contraceptives alone) while still on GLP-1 drugs
GLP-1 Drugs and Male Fertility
The fertility conversation is predominantly focused on women, but emerging research is examining GLP-1 drugs and male reproductive health. Obesity is associated with lower testosterone, reduced sperm quality, and erectile dysfunction. Weight loss through GLP-1 drugs improves testosterone levels and sperm parameters in obese men – though dedicated RCTs specifically on GLP-1 and male fertility outcomes are still limited. The early evidence is encouraging: the metabolic improvement that helps women may help men too.
Hormonal balance and fertility are highly sensitive to cortisol and chronic stress. Ashwagandha KSM-66 – the most bioavailable form – has clinical evidence for reducing cortisol by up to 30%, improving thyroid hormone levels, and in women, supporting hormonal regularity. If you are working on fertility, managing stress physiology is a meaningful complementary step. See this KSM-66 ashwagandha on Amazon.in – the most researched ashwagandha extract available in India.
Related: Can Ozempic Help with PCOS?
PCOS is the most common reason GLP-1 drugs are being considered for fertility. Read our full breakdown: Can Ozempic Help with PCOS? What the Research Actually Shows
Dr. Ajit Jha’s Clinical Perspective
“The fertility dimension of GLP-1 drugs is one of the most important clinical conversations I am having right now – and it is one that prescribing physicians are not always having with their patients. I have seen women who were told for years that pregnancy would be very difficult, start semaglutide for weight management, lose 12 to 15 kilograms over six months, and then find themselves pregnant – sometimes before they even realised their cycles had normalised. This is not a bad outcome – for women who want a child, it can be life-changing. But for women who are not planning pregnancy, it is a serious clinical risk that requires proactive contraception counselling from the moment the prescription is written. My clear advice: if you are a woman of reproductive age on a GLP-1 drug and you do not want to become pregnant right now, do not rely on the pill alone. Use an IUD or a reliable barrier method. And if you are planning to conceive, work with your doctor to time the discontinuation properly.”
– Dr. Ajit Jha, MD Medicine | IMA Lifetime Member | Editorial Board Member, International Journal of Diabetes and Endocrinology (IJDE)
Frequently Asked Questions
Can Ozempic make me more fertile?
Indirectly, yes – in women with PCOS, obesity, or insulin resistance where these conditions are suppressing ovulation. GLP-1-driven weight loss and insulin sensitisation can restore regular ovulation and improve fertility. However, Ozempic is not a fertility treatment and cannot overcome fertility challenges unrelated to metabolic health, such as structural issues, premature ovarian insufficiency, or male factor infertility.
Is it safe to take Ozempic while trying to get pregnant?
No. GLP-1 drugs are contraindicated in pregnancy and should be stopped at least two months before attempting conception. Animal studies show foetal harm at clinical doses. Use effective contraception while on these drugs, and plan your discontinuation timeline with your doctor well in advance of any conception attempt.
Does Ozempic affect the birth control pill?
Potentially, yes. GLP-1 drugs slow gastric emptying, which can reduce the absorption of oral contraceptive hormones and potentially reduce their effectiveness. Novo Nordisk and Eli Lilly both note this in their prescribing information. Women on GLP-1 drugs are advised to use IUDs or barrier contraception rather than relying solely on oral contraceptive pills.
How long after stopping Ozempic can I try to get pregnant?
Current medical guidance recommends waiting at least two months after stopping semaglutide before attempting conception. Semaglutide has a half-life of approximately one week, so it is largely cleared within five weeks – but two months provides an additional safety margin. For tirzepatide (Mounjaro), the same two-month recommendation applies.
📖 Related Articles